RNA splicing regulates prostate cancer progression to hormone therapy resistant neuroendocrine tumors

RNA剪接调节前列腺癌进展为激素治疗耐药的神经内分泌肿瘤

• 批准号: 370828
• 负责人: Dong Xuesen
• 金额: $ 50.99万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-09-01 至 2022-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=370828&lang=en
• 关键词: Hormone Therapy Resistance; Prostate Cancer

Prostate cancer affects one in every seven men in developed countries and is the second leading cause of cancer-related death in males. The incidence of this disease will grow with significant increases in life expectancy, creating a perpetual burden on o

在发达国家，每七名男性中就有一名患有前列腺癌，前列腺癌是男性癌症相关死亡的第二大原因。这种疾病的发病率将随着预期寿命的显著增加而增加，对人类造成永久性的负担。